SARS-CoV-2 Transmission Control Measures in the Emergency Department: The Role of Rapid Antigenic Testing in Asymptomatic Subjects.
COVID-19 transmission control
asymptomatic COVID-19
emergency department
rapid SARS-CoV-2 antigen testing
Journal
Healthcare (Basel, Switzerland)
ISSN: 2227-9032
Titre abrégé: Healthcare (Basel)
Pays: Switzerland
ID NLM: 101666525
Informations de publication
Date de publication:
23 Apr 2022
23 Apr 2022
Historique:
received:
21
03
2022
revised:
20
04
2022
accepted:
21
04
2022
entrez:
28
5
2022
pubmed:
29
5
2022
medline:
29
5
2022
Statut:
epublish
Résumé
Limiting transmission of SARS-CoV-2 from asymptomatic people assumes the paramount importance of keeping fragile subjects protected. We evaluated the utility of rapid SARS-CoV-2 antigen testing in asymptomatic subjects attending emergency departments in non-COVID-19 areas, using a single nasopharyngeal swab specimen collected in universal transport medium to perform both rapid antigen testing and rRT-PCR (used as reference standard) in a cohort of 899 patients. In the overall sample, the rapid antigen test had 43.9% sensitivity, 100% specificity, 100% positive predictive value, 93.6% negative predictive value. Considering subjects with rRT-PCR cycle threshold ≤30, the test had 80.4% sensitivity, 100% specificity, 100% positive predictive value, 98.8% negative predictive value. Considering subjects with rRT-PCR cycle threshold ≤25, the test had 94.7% sensitivity, 100% specificity, 100% positive predictive value and 99.7% negative predictive value. Despite low sensitivity, routine application of rapid antigen testing in the emergency department can lead to isolation in less than 30 min of about a half of asymptomatic COVID-19 subjects assigned to non-COVID-19 areas by clinical triage. The rapid test correctly identified 94.7% of asymptomatic patients with cycle threshold ≤ 25 that are supposed to be more infective; thus, it could be a useful measure to contain viral transmission in non-COVID-19 areas.
Identifiants
pubmed: 35627926
pii: healthcare10050790
doi: 10.3390/healthcare10050790
pmc: PMC9140606
pii:
doi:
Types de publication
Journal Article
Langues
eng
Références
Microbiol Spectr. 2021 Dec 22;9(3):e0133021
pubmed: 34908473
BMJ. 2022 Mar 9;376:e069761
pubmed: 35264324
Anal Bioanal Chem. 2022 Apr;414(9):2903-2934
pubmed: 35211785
Emerg Med J. 2020 May;37(5):252-254
pubmed: 32321705
Lab Chip. 2021 May 4;21(9):1634-1660
pubmed: 33705507
Lancet. 2022 Jan 29;399(10323):437-446
pubmed: 35065011
JAMA Netw Open. 2021 Dec 1;4(12):e2137257
pubmed: 34905008
Int J Infect Dis. 2020 Oct;99:397-402
pubmed: 32800855
J Med Virol. 2022 Apr;94(4):1723-1727
pubmed: 34873718
Curr Hepatol Rep. 2021;20(4):166-174
pubmed: 34725630
mBio. 2022 Apr 26;13(2):e0297921
pubmed: 35352979
Eur J Emerg Med. 2020 Jun;27(3):174-177
pubmed: 32243317
ACS Sens. 2020 Aug 28;5(8):2283-2296
pubmed: 32627534
Reprod Biomed Online. 2020 Sep;41(3):483-499
pubmed: 32651106
Eur Rev Med Pharmacol Sci. 2021 Jan;25(1):503-517
pubmed: 33506942
J Clin Epidemiol. 2022 May;145:14-19
pubmed: 35041972
MMWR Morb Mortal Wkly Rep. 2022 Apr 01;71(13):489-494
pubmed: 35358168
Nature. 2022 Mar;603(7902):679-686
pubmed: 35042229
BMJ Open. 2022 Jan 31;12(1):e054688
pubmed: 35105642
Clin Microbiol Infect. 2022 May;28(5):734.e1-734.e6
pubmed: 35065265
MedComm (2020). 2021 Dec 16;2(4):838-845
pubmed: 34957469
Diagn Microbiol Infect Dis. 2022 Apr;102(4):115635
pubmed: 35216863
Viruses. 2021 May 01;13(5):
pubmed: 34062916
Emerg Microbes Infect. 2022 Dec;11(1):1-5
pubmed: 34890524
Int J Environ Res Public Health. 2020 May 27;17(11):
pubmed: 32471066
J Virol Methods. 2022 Jan;299:114337
pubmed: 34687785
BMC Health Serv Res. 2021 Oct 25;21(1):1153
pubmed: 34696803
Diagn Pathol. 2022 Apr 13;17(1):36
pubmed: 35414002
Emerg Med Australas. 2020 Jun;32(3):511-514
pubmed: 32255567
Talanta. 2022 Jul 1;244:123409
pubmed: 35390680